<DOC>
	<DOCNO>NCT01006083</DOCNO>
	<brief_summary>The objective study evaluate safety antiplatelet ( APA ) therapy continuation patient undergo lumbar spine surgery ( laminectomy , discectomy foraminotomy ) , gather evidence-based data regard postoperative outcome potentially relate APA management .</brief_summary>
	<brief_title>Antiplatelet Therapy Continuation Spine Surgery - Its Effect Postoperative Morbidity Mortality</brief_title>
	<detailed_description>BACKGROUND Antiplatelet agent ( APAs ) widely prescribe coronary stenting , primary secondary prevention cerebrovascular coronary artery disease . Dual antiplatelet therapy ( aspirin/plavix ) become mainstay antiplatelet treatment strategy prevention stent thrombosis . Maintaining antiplatelet therapy end indicate period crucial success coronary stent . Premature discontinuation antiplatelet therapy markedly increase risk stent thrombosis , catastrophic event frequently lead myocardial infarction ( MI ) , death rate 20-40 % . Aspirin commonly prescribe lifetime patient increase atherothrombotic risk , whereas Plavix regard mandatory coronary stent fully endothelialized , take 4-6 week bare metal stent 1 yr drug-eluting stent . And yet , within first year stenting , approximately 5 % patient undergone percutaneous coronary intervention ( PCIs ) require noncardiac surgery , thus raise dilemmas APA management : stopping APA treatment operation avoid bleed risk postoperative stent thrombosis versus maintain APA therapy perioperatively thus risk extensive blood loss limit risk postoperative ischemic event . Current recommendation aspirin discontinue pre-operatively , exception brain surgery certain urological operation bleed may difficult control therefore life threatening . The continue use plavix perioperative period significantly increase intraoperative blood loss , re-operations control hemorrhage transfusion , affect morbidity , mortality , surgical outcome . Most guideline recommend postpone invasive procedure end indication plavix . Only vital emergency surgery perform full antiplatelet therapy , exception procedure even small hemorrhage may disastrous consequence ( e.g . intracranial surgery , spinal surgery medullary canal , surgery posterior chamber eye ) , procedures involve massive bleeding . Evidence-based data need guide management patient early antiplatelet withdrawal consider ( e.g . require non-cardiac surgery ) . Several study conduct orthopedic cardiac surgery , however , best knowledge , spine surgery . This type surgery might often semi-urgent postpone surgery long time may problematic . This prospective , observational study design evaluate safety APA therapy continuation patient admit lumbar spine surgery . METHODS Study design The study conduct observational one . An informed consent obtain patient match criterion . Diuretics oral hypoglycemics discontinue day prior surgery , dictate routine patient . Antiplatelet therapy continue commonly practiced procedure . Any deviation protocol document . Throughout postoperative period study patient observe bleeding- thrombosis-related event , relevant perioperative data document ( see `` patient monitoring &amp; assessment '' ) . Peri-operative management Anesthetic surgical management , include management surgical hemorrhage hemodynamic event adhere standard practice . Postoperatively , study patient transfer post-anesthesia care unit later neurosurgery department , unless otherwise indicate . In postoperative period , departmental routine guide blood product transfusion , pain management , fluid regimen medication administer . Patient monitoring &amp; assessment Patients allocate 4 group : 1 . Patients risk coronary and/or cerebrovascular disease , take APAs . 2 . Patients high risk cardio/cerebrovascular disease ( diabetes mellitus , cigarette smoking , hypercholesterolemia , hypertension , morbid obesity ) , take APAs . 3 . High-risk patient cardiovascular risk factor ( ) , APA prescribe primary prevention coronary artery disease ( CAD ) . 4 . Patients history coronary syndrome ( stable/unstable angina ) ; MI ; transient ischemic attack ( TIA ) /stroke ; severe carotid artery stenosis/stenting ; peripheral vascular disease , APAs secondary prevention . For consented patient include study record demographic medical history ; chronic medication ; detail cardiovascular history ; neurological examination ; APA-related data : type dose APA take ; indication ; Intra-operative data ; perioperative complication . Outcome measure 1 . Primary outcome : hemorrhagic , thrombotic , neurological complication Include complication , morbidity death potentially cause continuation ( e.g. , direct indirect hemorrhage ; hemorrhagic CVA ) withdrawal APA therapy ( e.g. , MI ; PE ; ischemic CVA ; DVT ; etc . ) , occur discharge , within 30 postoperative day . Neurological complication may relate surgery ; bleeding ; thrombosis ; , classify accordingly . 2 . Secondary outcome Include : re-intubations ; transfer ICU ; length stay ( LOS ) ; re-admissions within 7 / 30 day ; major morbidity death 30 60 day postoperatively . Study size The study expect last 2 year , include approximately 200 patient . REFERENCES 1 . Anderson , J.L. , et al. , ACC/AHA 2007 guideline management patient unstable angina/non-ST-Elevation myocardial infarction : report American College Cardiology/American Heart Association Task Force Practice Guidelines ( Writing Committee Revise 2002 Guidelines Management Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction ) develop collaboration American College Emergency Physicians , Society Cardiovascular Angiography Interventions , Society Thoracic Surgeons endorse American Association Cardiovascular Pulmonary Rehabilitation Society Academic Emergency Medicine . J Am Coll Cardiol , 2007 . 50 ( 7 ) : p. e1-e157 . 2 . Fox , K.A. , et al. , Benefits risk combination clopidogrel aspirin patient undergoing surgical revascularization non-ST-elevation acute coronary syndrome : Clopidogrel Unstable angina prevent Recurrent ischemic Events ( CURE ) Trial . Circulation , 2004 . 110 ( 10 ) : p. 1202-8 . 3 . Hirsch , A.T. , et al. , ACC/AHA 2005 Practice Guidelines management patient peripheral arterial disease ( low extremity , renal , mesenteric , abdominal aortic ) : collaborative report American Association Vascular Surgery/Society Vascular Surgery , Society Cardiovascular Angiography Interventions , Society Vascular Medicine Biology , Society Interventional Radiology , ACC/AHA Task Force Practice Guidelines ( Writing Committee Develop Guidelines Management Patients With Peripheral Arterial Disease ) : endorse American Association Cardiovascular Pulmonary Rehabilitation ; National Heart , Lung , Blood Institute ; Society Vascular Nursing ; TransAtlantic Inter-Society Consensus ; Vascular Disease Foundation . Circulation , 2006 . 113 ( 11 ) : p. e463-654 . 4 . Keller , T.T. , A. Squizzato , S. Middeldorp , Clopidogrel plus aspirin versus aspirin alone prevent cardiovascular disease . Cochrane Database Syst Rev , 2007 ( 3 ) : p. CD005158 . 5 . Smith , S.C. , Jr. , et al. , AHA/ACC guideline secondary prevention patient coronary atherosclerotic vascular disease : 2006 update : endorsed National Heart , Lung , Blood Institute . Circulation , 2006 . 113 ( 19 ) : p. 2363-72 . 6 . Weitz , J.I. , J. Hirsh , M.M . Samama , New antithrombotic drug : American College Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition ) . Chest , 2008 . 133 ( 6 Suppl ) : p. 234S-256S . 7 . Grines , C.L. , et al. , Prevention premature discontinuation dual antiplatelet therapy patient coronary artery stent : science advisory American Heart Association , American College Cardiology , Society Cardiovascular Angiography Interventions , American College Surgeons , American Dental Association , representation American College Physicians . Circulation , 2007 . 115 ( 6 ) : p. 813-8 . 8 . Iakovou , I. , et al. , Incidence , predictor , outcome thrombosis successful implantation drug-eluting stent . JAMA , 2005 . 293 ( 17 ) : p. 2126-30 . 9 . Patrono , C. , et al. , Antiplatelet drug : American College Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition ) . Chest , 2008 . 133 ( 6 Suppl ) : p. 199S-233S . 10 . Pfisterer , M. , et al. , Late clinical event clopidogrel discontinuation may limit benefit drug-eluting stent : observational study drug-eluting versus bare-metal stent . J Am Coll Cardiol , 2006 . 48 ( 12 ) : p. 2584-91 . 11 . Ong , A.T. , et al. , Late angiographic stent thrombosis ( LAST ) event drug-eluting stent . J Am Coll Cardiol , 2005 . 45 ( 12 ) : p. 2088-92 . 12 . Schouten , O. , J.J. Bax , D. Poldermans , Management patient cardiac stent undergo noncardiac surgery . Curr Opin Anaesthesiol , 2007 . 20 ( 3 ) : p. 274-8 . 13 . Laffey , J.G. , J.F . Boylan , D.C. Cheng , The systemic inflammatory response cardiac surgery : implication anesthesiologist . Anesthesiology , 2002 . 97 ( 1 ) : p. 215-52 . 14 . Priebe , H.J. , Triggers perioperative myocardial ischaemia infarction . Br J Anaesth , 2004 . 93 ( 1 ) : p. 9-20 . 15 . Ho , P.M. , et al. , Incidence death acute myocardial infarction associate stop clopidogrel acute coronary syndrome . JAMA , 2008 . 299 ( 5 ) : p. 532-9 . 16 . Ferrari , E. , et al. , Coronary syndromes follow aspirin withdrawal : special risk late stent thrombosis . J Am Coll Cardiol , 2005 . 45 ( 3 ) : p. 456-9 . 17 . Sharma , A.K. , et al. , Major noncardiac surgery follow coronary stenting : safe operate ? Catheter Cardiovasc Interv , 2004 . 63 ( 2 ) : p. 141-5 . 18 . Chassot , P.G. , A. Delabays , D.R . Spahn , Perioperative antiplatelet therapy : case continue therapy patient risk myocardial infarction . Br J Anaesth , 2007 . 99 ( 3 ) : p. 316-28 . 19 . Chu , M.W. , et al. , Does clopidogrel increase blood loss follow coronary artery bypass surgery ? Ann Thorac Surg , 2004 . 78 ( 5 ) : p. 1536-41 . 20 . Douketis , J.D. , et al. , The perioperative management antithrombotic therapy : American College Chest Physicians Evidence-Based Clinical Practice Guidelines ( 8th Edition ) . Chest , 2008 . 133 ( 6 Suppl ) : p. 299S-339S .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Aged &gt; 18 year old , Undergoing elective urgent spinal surgery , Included procedure aim decompress spinal canal lumbar region due degenerative disease , i.e. , laminectomy , discectomy foraminotomies . Patients infectious disease , tumor resection , trauma case , Patients require lumbar fixation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Plavix</keyword>
	<keyword>antiplatelet therapy</keyword>
	<keyword>Hemorrhage</keyword>
	<keyword>ischemic event</keyword>
</DOC>